Factors Influencing the Effectiveness of Oseltamivir and Amantadine for the Treatment of Influenza: A Multicenter Study from Japan of the 2002--2003 Influenza Season
- 1 May 2005
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 40 (9) , 1309-1316
- https://doi.org/10.1086/429241
Abstract
Background. To evaluate the effectiveness of oseltamivir and amantadine for the treatment of influenza with respect to various clinical factors, a prospective multicenter study of the influenza season of 2002–2003 was done with 2163 patients whose condition was diagnosed by an antigen-detection test kit.Keywords
This publication has 14 references indexed in Scilit:
- Effectiveness of neuraminidase inhibitors in treatment and prevention of influenza A and B: systematic review and meta-analyses of randomised controlled trialsBMJ, 2003
- Early therapy with the neuraminidase inhibitor oseltamivir maximizes its efficacy in influenza treatmentMedical Microbiology and Immunology, 2002
- Early administration of oral oseltamivir increases the benefits of influenza treatmentJournal of Antimicrobial Chemotherapy, 2002
- Susceptibility of recent Canadian influenza A and B virus isolates to different neuraminidase inhibitorsAntiviral Research, 2002
- Antiviral therapy of influenzaSeminars in Pediatric Infectious Diseases, 2002
- Symptom pathogenesis during acute influenza: Interleukin‐6 and Other cytokine responsesJournal of Medical Virology, 2001
- OseltamivirDrugs, 2001
- Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trialThe Lancet, 2000
- Influenza virus neuraminidase inhibitorsThe Lancet, 2000
- Efficacy and Safety of the Oral Neuraminidase Inhibitor Oseltamivir in Treating Acute InfluenzaJAMA, 2000